Jerini
Latest round
- Series B
Last raised
- Feb 2005
Total raised
- $58M
Investors
- 10
About Jerini
Jerini AG was a Germany-based biopharmaceutical and biotechnology company headquartered in Berlin, Germany. Founded in 1994, the company specialized in the discovery and development of peptide-based therapeutics for diseases with limited or inadequate treatment options. Jerini developed a proprietary Peptides-to-Drugs (P2D) technology platform used to identify and optimize novel drug candidates.
Who invested in Jerini
10 investors across 3 rounds
See all investors in Jerini
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jerini
Who invested in Jerini?
Jerini has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jerini raised?
Jerini has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Jerini last raise money?
Jerini's most recent round on record is a Series B, in Feb 2005.
What does Jerini do?
Jerini AG was a Germany-based biopharmaceutical and biotechnology company headquartered in Berlin, Germany.
Where is Jerini headquartered?
Jerini is headquartered in Berlin, Germany.
Which VCs invest in companies like Jerini?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Jerini's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Jerini? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.